4415-11-6 Usage
Uses
Used in Medicinal Chemistry Research:
3-(2-CHLORO-6-FLUOROPHENYL)-5-METHYLISOXAZOLE-4-CARBOXAMIDE is used as a research compound in medicinal chemistry for the development of potential pharmaceutical drugs. Its specific biological activities and potential therapeutic applications are not widely documented, but its structural characteristics suggest that it may have the potential to be a promising candidate for drug discovery.
Used in Pharmaceutical Drug Development:
In the pharmaceutical industry, 3-(2-CHLORO-6-FLUOROPHENYL)-5-METHYLISOXAZOLE-4-CARBOXAMIDE is used as a precursor or intermediate in the synthesis of new drug molecules. Its unique structural features may contribute to the development of innovative therapeutic agents with novel mechanisms of action.
Used in Organic Chemistry Synthesis:
3-(2-CHLORO-6-FLUOROPHENYL)-5-METHYLISOXAZOLE-4-CARBOXAMIDE is also used in organic chemistry as a building block or synthetic intermediate for the preparation of various organic compounds. Its reactivity and functional group compatibility make it a valuable component in the synthesis of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 4415-11-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,4,1 and 5 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 4415-11:
(6*4)+(5*4)+(4*1)+(3*5)+(2*1)+(1*1)=66
66 % 10 = 6
So 4415-11-6 is a valid CAS Registry Number.
InChI:InChI=1/C4H3F7O3S/c5-2(6)3(7,8)1-14-15(12,13)4(9,10)11/h2H,1H2
4415-11-6Relevant academic research and scientific papers
1-(4-(ISOXAZOL-5-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS IL-17 AND IFN-GAMMA INHIBITORS FOR TREATING AUTOIMMUNE DISEASES AND CHRONIC INFLAMMATION
-
Page/Page column 26; 32; 33, (2019/04/10)
The present invention relates to compounds of the general formula (I), and the pharmaceutically acceptable salts and solvates thereof, wherein Ar, Z and Y are as described herein and R1 is a group of the structure (formula (II)), wherein n is 0 or 1; R2 is H, deuterium or methyl; R3 is methyl, trilluoromethyl, ethyl, or taken with R2 together forms a cyclopropyl group, or R3 forms a methylene bridge to the carbon atom marked *, which are suitable for the treatment of autoimmune diseases and chronic inflammation.
